Description: BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceuticals, pharmaceutical preparations, pharmaceutical substances, medications, and other pharmaceutical products in Poland, China, Thailand, Vietnam, Libya, Argentina, Ukraine, Malta, Yemen, and the Russian Federation. The company offers recombinant human and classic insulin; oral anti-diabetic medication products; dietary supplements; strips for measuring sugar in blood, as well as OTC preparation for diabetics; diabetics drugs insulin vials and cartridges, including Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. It engages in advertising, advisory, and company management activities. The company was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
Home Page: www.bioton.pl
ul. Poznanska 12
Ozarów Mazowiecki,
05-850
Poland
Phone:
48 22 721 4000
Officers
| Name | Title |
|---|---|
| Mr. Jeremy Launders | Pres of the Management Board |
| Mr. Adam Tomasz Polonek | Member of Management Board |
| Ms. Anna Grabowska | Sr. Fin. Mang. |
| Mr. Michal Deptuch | Operations Director |
| Renata Prokopczyk | Chief Accountant |
| Ms. Kamila Musnicka | Director of Legal Department |
| Ms. Joanna Sadowska | HR Director |
| Mr. Mateusz Patryk Kosecki | Head of Biolek Bus. Unit & CEO of Biolek Sp. Z O.O. |
Exchange: WAR
Country: PL : Poland
Currency: Polish złoty (zł)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 114.3333 |
| Price-to-Book MRQ: | 0.4929 |
| Price-to-Sales TTM: | 1.4896 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 375 |